Keyphrases
Focal Segmental Glomerulosclerosis
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Kidney Transplant
100%
Rituximab
100%
Therapeutic Plasma Exchange
100%
Proteinuria
50%
Transplantation
16%
Podocyte
16%
Rituximab Therapy
16%
Integrin Activity
16%
Response to Therapy
8%
Odds Ratio
8%
Serum Creatinine
8%
Recurrence Rate
8%
Combined Therapy
8%
Age of Diagnosis
8%
Age at Diagnosis
8%
Kidney Disease Progression
8%
Multi-centered
8%
Study Monitoring
8%
Proteinuria Reduction
8%
Medicine and Dentistry
Kidney Graft
100%
Rituximab
100%
Plasma Exchange
100%
Focal Segmental Glomerulosclerosis
100%
Proteinuria
77%
Transplantation
33%
Integrin
22%
Podocyte
22%
Recurrent Disease
11%
Biological Marker
11%
Combined Therapy
11%
Creatinine
11%
Prospective Study
11%
Chronic Kidney Disease
11%
Odds Ratio
11%
Pharmacology, Toxicology and Pharmaceutical Science
Proteinuria
100%
Rituximab
100%
Focal Glomerulosclerosis
100%
Integrin
28%
Biological Marker
14%
Recurrent Disease
14%
Prospective Study
14%
Chronic Kidney Failure
14%
Creatinine
14%
Biochemistry, Genetics and Molecular Biology
Rituximab
100%
Focal Segmental Glomerulosclerosis
100%
Blood Plasma
100%
Integrin
22%
Podocyte
22%
Prospective Study
11%
Creatinine Blood Level
11%
Immunology and Microbiology
Blood Plasma
100%
Rituximab
100%
Integrin
22%
Podocyte
22%
Creatinine Blood Level
11%